Announced Thu, 14 Aug · 19:12 IST

Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2025 ,inter alia, to consider and approve the request letter ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Chemo Pharma Laboratories Ltd has informed BSE that its Board of Directors will meet on Friday, August 21, 2025, at 4:00 PM at the registered office in Kalyan, Thane. The main item on the agenda is to consider and approve a request letter dated August 11, 2025 from Ms. Shanta Somani, who is seeking reclassification of her shareholding status from 'Promoter Group Shareholder' to 'Public Shareholder' under SEBI's Regulation 31A. The reclassification is subject to approval from the stock exchanges and any other necessary regulatory approvals. The notice has also been uploaded on the company's website.

Likely market impact

If approved by the Board and stock exchanges, Ms. Shanta Somani will move out of the promoter group category and be treated as a public shareholder. This will reduce the promoter group shareholding technically but is generally seen as a routine procedural step rather than a material change for the stock price.